x
Filter:
Filters applied
- ACMG Statements and Guidelines
- Chromosomal microarrayRemove Chromosomal microarray filter
- 2020 - 2022Remove 2020 - 2022 filter
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG Technical Standard
Interpretation and reporting of large regions of homozygosity and suspected consanguinity/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 24Issue 2p255–261Published online: December 3, 2021- Patrick R. Gonzales
- Erica F. Andersen
- Teneille R. Brown
- Vanessa L. Horner
- Juli Horwitz
- Catherine W. Rehder
- and others
Cited in Scopus: 1Genomic testing, including single-nucleotide variation (formerly single-nucleotide polymorphism)–based chromosomal microarray and exome and genome sequencing, can detect long regions of homozygosity (ROH) within the genome. Genomic testing can also detect possible uniparental disomy (UPD). Platforms that can detect ROH and possible UPD have matured since the initial American College of Medical Genetics and Genomics (ACMG) standard was published in 2013, and the detection of ROH and UPD by these platforms has shown utility in diagnosis of patients with genetic/genomic disorders.
